Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Cancer Therapeutics|January 22, 2011
sFLT01: a novel fusion protein with antiangiogenic activityRebecca G Bagley, Leslie Kurtzberg, William Weber, et al.
Molecular Therapy. Methods & Clinical Development|January 19, 2023
Preclinical studies in support of phase I/II clinical trials to treat <i>GUCY2D</i>-associated Leber congenital amaurosisSanford L Boye, Catherine O'Riordan, James Morris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse modelJohn Marshall, Kerry Anne McEachern, Julie A Cavanagh Kyros, et al.
Blood|November 21, 2007
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivoMelanie C Ruzek, James S Waire, Deborah Hopkins, et al.
Stroke|March 23, 2017
Soluble FLT1 Gene Therapy Alleviates Brain Arteriovenous Malformation SeverityWan Zhu, Fanxia Shen, Lei Mao, et al.
Plos One|May 1, 2014
Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degenerationDaniel Ardeljan, Yujuan Wang, Stanley Park, et al.
Lancet (London, England)|May 21, 2017
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trialJeffrey S Heier, Saleema Kherani, Shilpa Desai, et al.
Human Gene Therapy|March 13, 2014
Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
Diabetes|November 28, 2007
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulationGreg Simon, Matthew Parker, Vijayakumar Ramiya, et al.
Nature Communications|July 10, 2021
Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleasesMoritz J Schmidt, Ashish Gupta, Christien Bednarski, et al.
Pageof 3